Polygiene Group AB (STO:POLYG)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 248.38M |
| Revenue (ttm) | 136.17M |
| Net Income (ttm) | -6.77M |
| Shares Out | 36.53M |
| EPS (ttm) | -0.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.27 (3.97%) |
| Ex-Dividend Date | Sep 30, 2025 |
| Volume | 1,512 |
| Average Volume | 3,957 |
| Open | 6.80 |
| Previous Close | 6.80 |
| Day's Range | 6.80 - 6.80 |
| 52-Week Range | 5.36 - 13.80 |
| Beta | 1.49 |
| RSI | 46.68 |
| Earnings Date | Apr 16, 2026 |
About Polygiene Group AB
Polygiene Group AB provides antimicrobial technologies for textiles and other hard surfaces in the Asia Pacific, Europe, the Middle East, Africa, the United States, and internationally. It operates through two segments: Polygiene and Addmaster. The company offers solutions and treatments for products with technologies, such as OdorCrunch, StayFresh, ScentMaster, ViralOff, BioMaster, and VeriMaster. It also provides antimicrobial, antiviral, and odor control solutions. The company serves partners across various categories, such as sports and out... [Read more]
Financial Performance
Financial StatementsNews
Polygiene Group AB Earnings Call Transcript: Q1 2026
Q1 sales declined 25% year-over-year, but gross margin improved to 69.5% due to disciplined pricing and cost control. Addmaster became the largest segment, while Polygiene sales dropped sharply. Innovation and actions to restore Americas growth are underway.
Polygiene Group AB Earnings Call Transcript: Q4 2025
Q4 sales fell 17.7% year-over-year, mainly due to FX and lower Polygiene sales, while Addmaster remained stable. Gross margin and EBITDA declined, impacted by FX and one-time CEO transition costs. Silver price volatility and regional demand shifts remain key challenges.
Polygiene Group AB Earnings Call Transcript: Q3 2025
Q3 saw improved performance with Polygiene recovering and Addmaster lagging, but both segments show signs of recovery for Q4. Sales declined mainly due to FX, but new product launches and strong orders support a positive outlook.
Polygiene Group AB Earnings Call Transcript: Q2 2025
Second quarter results were heavily impacted by tariffs and currency effects, leading to a 12% sales decline and negative EBITDA. Despite challenges, new product launches and a strategic U.S. partnership signal future growth, with recovery expected as external factors stabilize.
Polygiene Group AB Earnings Call Transcript: Q1 2025
Revenue grew 18% year-over-year, with Polygiene segment up 42% and Admaster flat as expected. Gross margin remained strong at 67.4%, and the board proposed the first-ever dividend. New technologies and global expansion support a positive outlook for 2025.
Polygiene Group AB Earnings Call Transcript: Q4 2024
Sales grew 45% year-over-year, with strong Q4 margins and a proposed SEK 0.05 dividend. Both Polygiene and Addmaster segments saw robust growth, and new partnerships and product launches support a positive outlook for 2025.
Polygiene Group AB Earnings Call Transcript: Q3 2024
Sales grew 42% year-over-year to SEK 40.8 million, with strong EBITDA and positive cash flow. Both Polygiene and Addmaster segments delivered robust growth, supported by new partnerships and innovation projects. Cash position remains strong and the company is debt-free.
Polygiene Group AB Earnings Call Transcript: Q2 2024
Q2 saw 43% sales growth, improved profitability, and strong cash flow, driven by APAC—especially China—and successful business area separation. Gross margin declined due to mix and currency, but cost controls and innovation projects support a positive outlook.